Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...

Veracyte (NasdaqGM:VCYT) reported new predictive data on its Decipher Prostate Genomic Classifier in very high-risk ...

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

Prostate cancer is common. About 200 in every 1,000 Australian men will be told they have prostate cancer by age 85. But the chance of dying from it is much lower: around 18 in 1,000 cases.

Hello everyone. I am Tetsuya Kubota, Director of Kubota Clinic Matsudo Goko and a urology specialist.It can be quite a shock ...

Add Yahoo as a preferred source to see more of our stories on Google. Prostate cancer blood tests ‘can lead to men being over-tested’, experts say Prostate cancer blood tests can lead to men being ...

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...

It is easy to assume that the prostate is healthy when there is no usual discomfort during urination. However, prostate ...

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its Decipher® Prostate Genomic Classifier can predict benefit from adding abiraterone to androgen ...

To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...

Learn about the spit test that has shown promising results for detecting prostate cancer risk, proving to be more reliable than common blood tests. Prostate cancer is one of the primary health scares ...

Prostate cancer blood tests can lead to men being over-tested, while those who need help may be missed, a large study has found. Researchers from the University of Oxford examined the health records ...